Detalhe da pesquisa
1.
The prevalence, burden of disease, and healthcare utilization of patients with eosinophilic granulomatosis with polyangiitis in Japan: a retrospective, descriptive cohort claims database study.
Mod Rheumatol
; 32(2): 380-386, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894250
2.
Improved Dissolution of Dipyridamole with the Combination of pH-Modifier and Solid Dispersion Technology.
Chem Pharm Bull (Tokyo)
; 65(5): 426-431, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28458364
3.
Physicochemical stability study on cyclosporine A loaded dry-emulsion formulation with enhanced solubility.
Chem Pharm Bull (Tokyo)
; 63(1): 54-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25743195
4.
Inhalable powder formulation of pirfenidone with reduced phototoxic risk for treatment of pulmonary fibrosis.
Pharm Res
; 30(6): 1586-96, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23430486
5.
Enhanced biopharmaceutical effects of tranilast on experimental colitis model with use of self-micellizing solid dispersion technology.
Int J Pharm
; 545(1-2): 19-26, 2018 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29702241
6.
Improved oral absorption profile of itraconazole in hypochlorhydria by self-micellizing solid dispersion approach.
Eur J Pharm Sci
; 97: 55-61, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27810562
7.
Avoidance of food effect on oral absorption profile of itraconazole by self-micellizing solid dispersion approach.
Drug Metab Pharmacokinet
; 32(5): 273-276, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28923421
8.
Protective effects of tranilast on experimental colitis in rats.
Biomed Pharmacother
; 90: 842-849, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28437888
9.
Strategic application of self-micellizing solid dispersion technology to respirable powder formulation of tranilast for improved therapeutic potential.
Int J Pharm
; 499(1-2): 255-262, 2016 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26748364
10.
Self-micellizing solid dispersion of cyclosporine A with improved dissolution and oral bioavailability.
Eur J Pharm Sci
; 62: 16-22, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24836392
11.
Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy.
Int J Pharm
; 448(1): 282-9, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23528280
12.
Development of novel solid dispersion of tranilast using amphiphilic block copolymer for improved oral bioavailability.
Int J Pharm
; 452(1-2): 220-6, 2013 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23694807
13.
Respirable dry powder formulation of bleomycin for developing a pulmonary fibrosis animal model.
J Pharm Sci
; 101(6): 2074-81, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22388976
14.
Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
Drug Metab Pharmacokinet
; 27(4): 379-87, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22240843
15.
Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats.
Eur J Pharm Biopharm
; 80(1): 54-60, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22008148
16.
Inhalable sustained-release formulation of long-acting vasoactive intestinal peptide derivative alleviates acute airway inflammation.
Peptides
; 35(2): 182-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22484228
17.
Formulation design and in vivo evaluation of dry powder inhalation system of new vasoactive intestinal peptide derivative ([R(15, 20, 21), L(17), A(24,25), des-N(28)]-VIP-GRR) in experimental asthma/COPD model rats.
Int J Pharm
; 410(1-2): 54-60, 2011 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21419198